By James Fraser, Tax Partner, Armstrong Watson LLP
HMRC recently published their draft guidance around how the mechanics of the relief is due to change. Some of these changes include extending the range of qualifying expenditure, a refocus on inward innovation and enhanced claim management using digital input.
The proposed changes will see the introduction of expenditure previously deemed ineligible, while also putting measures in place to allow HMRC to fight against the number of spurious or fraudulent claims being submitted. These changes will take effect for accounting periods from April 1, 2023. Consideration of these draft rules will have to be given where a company’s accounting period overlaps the date from which the new rules come into effect.
Extending qualifying expenditure This change in legislation has been well publicised in recent months. The purpose is to incentivise modern computational approaches, and as such, qualifying expenditure now includes: * The cost of data sets and cloud computing, whilst * Removing the exclusion of pure mathematics.
Refocusing on inward innovation The cost of subcontractors and externally provided works will be limited to focus on UK activity only, with some narrow exemptions in place. These exemptions will not include costs or workforce availability.
Enhanced claim management All claims for R&D tax relief will need to be submitted digitally (unless a company is exempt from filing online). All digital claims will need to provide detailed analysis of the qualifying costs and brief explanations of the R&D taking place.
Companies making a claim for the first time will need to inform HMRC of their intention to make a claim. They must do this within six months of the end of the financial period in question.
Other changes include: * Claims will need to include the details of the adviser who has assisted in the preparation of the claim and * The new Health & Social Care Levy will represent a new qualifying R&D cost. The legislation will be updated to enable this cost to be claimed.
For support in submitting an R&D claim, contact James Fraser on 0808 144 5575 or email james.fraser@armstrongwatson.co.uk.
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here